B+
Bull case
25%
Probability
Target price
$27.00
Analysis reference price unavailable
Analysis 2026-09-18 · RankAlpha Sentiment Codex
SIBN
SI-BONEDNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Approximately 15% revenue and procedure growth, 19% physician-base expansion, positive adjusted EBITDA and operating cash flow, improved reimbursement, and a pending breakthrough-device launch create several identifiable growth levers. [#SEC-8K-2026-08-03]
Posture
Defensive
Lead driver
Sentiment
What changed
Next scheduled catalyst: earnings 2026-11-02 · AMC.
What can break
A 79.5% Q2 gross margin was slightly below 79.8% a year earlier, while operating expenses rose 7.7% amid commercial activity and product rollout. [#SEC-8K-2026-08-03]
Momentum
82
Value
36
Sentiment
48
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $22.00 · Bull $27.00 · Bear $14.00Analysis 2026-09-18; returns require an exact persisted reference.
Earnings
2026-11-02 · AMC
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-26 • Vendor: Data Vendor v1
Scores
As of 2026-10-26 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-18 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-26
Investment thesis
As of 2026-10-26
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-26. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $25.44
Why
Momentum82 · Δ7d +4.2
Value36 · Δ7d +0.0
Sentiment48 · Δ7d -12.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-11-02 · AMC.
- • Sentiment remains the lead driver in the composite, 7D delta -12.0.
Contradictions & invalidation
- • A 79.5% Q2 gross margin was slightly below 79.8% a year earlier, while operating expenses rose 7.7% amid commercial activity and product rollout. [#SEC-8K-2026-08-03]
- • Recent open-market sales by senior executives and a director create a sentiment overhang, though the supplied Form 4 evidence does not establish motive or a change in business conditions. [#SEC-FORM4-2026-08-21] [#SEC-FORM4-2026-08-26] [#SEC-FORM4-2026-09-03]
- • Clearance or launch delays, weak initial utilization, or failure to translate physician growth into territory productivity could undermine the thesis.
Catalyst clock
2026-11-02 · AMC
Higher inpatient reimbursement takes effect
Lead driver: Sentiment · See AI snapshot
Momentum
82
8% active weight
Current posture
7d trendFlat
Δ7d
+4.2
Δ21d
+8.2
Value
36
47% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
48
45% active weight
Current posture
7d trendSoftening
Δ7d
-12.0
Δ21d
-31.8
Why this grade
Composite grade D. Momentum 82.1 / Value 36.4 / Sentiment 47.6
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-18. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$22.00
Analysis reference price unavailable
Analysis 2026-09-18 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$14.00
Analysis reference price unavailable
Analysis 2026-09-18 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-26
Fundamentals (TTM)
As of 2026-10-26
Market Cap
$955.08M
Beta
0.69
Shares Out
44.82M
P/E (TTM) · Derived
-48.4
P/S (TTM)
4.48
P/FCF (TTM) · Derived
-213.74
Rev YoY
+15.2%
EPS YoY
-36.1%
Gross Margin
+79.5%
Op Margin
-8.3%
Net Debt
-$111.14M
Current Ratio
9.15
As of 2026-10-26 • Updated nightlySource: Internal modelMethods & Data